GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Liabilities-to-Assets

PharmaTher Holdings (XCNQ:PHRM) Liabilities-to-Assets : 0.09 (As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. PharmaTher Holdings's Total Liabilities for the quarter that ended in Feb. 2024 was C$0.25 Mil. PharmaTher Holdings's Total Assets for the quarter that ended in Feb. 2024 was C$2.91 Mil. Therefore, PharmaTher Holdings's Liabilities-to-Assets Ratio for the quarter that ended in Feb. 2024 was 0.09.


PharmaTher Holdings Liabilities-to-Assets Historical Data

The historical data trend for PharmaTher Holdings's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Liabilities-to-Assets Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Liabilities-to-Assets
0.06 0.03 0.14

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.14 0.16 0.15 0.09

Competitive Comparison of PharmaTher Holdings's Liabilities-to-Assets

For the Biotechnology subindustry, PharmaTher Holdings's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaTher Holdings's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaTher Holdings's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where PharmaTher Holdings's Liabilities-to-Assets falls into.



PharmaTher Holdings Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

PharmaTher Holdings's Liabilities-to-Assets Ratio for the fiscal year that ended in May. 2023 is calculated as:

Liabilities-to-Assets (A: May. 2023 )=Total Liabilities/Total Assets
=0.892/6.31
=0.14

PharmaTher Holdings's Liabilities-to-Assets Ratio for the quarter that ended in Feb. 2024 is calculated as

Liabilities-to-Assets (Q: Feb. 2024 )=Total Liabilities/Total Assets
=0.252/2.914
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaTher Holdings  (XCNQ:PHRM) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


PharmaTher Holdings Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaTher Holdings (XCNQ:PHRM) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines